nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA2C—Hemostasis—IGF2—adrenal gland cancer	0.00159	0.00159	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—PRKACA—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—GNAS—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—TSHR—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00148	0.00148	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—SDHD—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—RRM1—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00142	0.00142	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00142	0.00142	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—POMC—adrenal gland cancer	0.00141	0.00141	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00139	0.00139	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00135	0.00135	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.00134	0.00134	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TSHR—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00127	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TSHR—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MEN1—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MEN1—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TSHR—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MED12—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000997	0.000997	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.000984	0.000984	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000981	0.000981	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000976	0.000976	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000969	0.000969	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000965	0.000965	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000947	0.000947	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.000943	0.000943	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000932	0.000932	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.00093	0.00093	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000928	0.000928	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.000925	0.000925	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000919	0.000919	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000914	0.000914	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000912	0.000912	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000911	0.000911	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000907	0.000907	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000905	0.000905	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000905	0.000905	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000902	0.000902	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000895	0.000895	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000891	0.000891	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.000879	0.000879	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000871	0.000871	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000864	0.000864	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000851	0.000851	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000847	0.000847	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000844	0.000844	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000838	0.000838	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000828	0.000828	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000827	0.000827	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000825	0.000825	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00081	0.00081	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000804	0.000804	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000796	0.000796	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000791	0.000791	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.000789	0.000789	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000782	0.000782	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000775	0.000775	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00077	0.00077	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000766	0.000766	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000759	0.000759	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000756	0.000756	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000747	0.000747	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000747	0.000747	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000741	0.000741	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000735	0.000735	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000732	0.000732	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000725	0.000725	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000723	0.000723	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000723	0.000723	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000719	0.000719	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000708	0.000708	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000706	0.000706	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000702	0.000702	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000671	0.000671	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000664	0.000664	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000661	0.000661	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.00066	0.00066	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000653	0.000653	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000649	0.000649	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000641	0.000641	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.00064	0.00064	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.00064	0.00064	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000634	0.000634	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000628	0.000628	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.000622	0.000622	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000618	0.000618	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.00061	0.00061	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000609	0.000609	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.0006	0.0006	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000599	0.000599	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000587	0.000587	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000577	0.000577	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000577	0.000577	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000572	0.000572	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.00056	0.00056	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000558	0.000558	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000551	0.000551	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000545	0.000545	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000541	0.000541	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.00054	0.00054	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000539	0.000539	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000536	0.000536	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000535	0.000535	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000533	0.000533	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000532	0.000532	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000531	0.000531	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.00053	0.00053	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000526	0.000526	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000522	0.000522	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000519	0.000519	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000513	0.000513	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.00051	0.00051	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000504	0.000504	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000499	0.000499	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000495	0.000495	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000493	0.000493	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000489	0.000489	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000488	0.000488	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000482	0.000482	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000481	0.000481	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000477	0.000477	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000472	0.000472	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000468	0.000468	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000467	0.000467	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000463	0.000463	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000456	0.000456	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000455	0.000455	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000449	0.000449	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000442	0.000442	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000438	0.000438	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000434	0.000434	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000431	0.000431	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000427	0.000427	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000424	0.000424	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000422	0.000422	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000418	0.000418	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.00041	0.00041	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000409	0.000409	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000392	0.000392	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000391	0.000391	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000385	0.000385	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000384	0.000384	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000381	0.000381	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000369	0.000369	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000365	0.000365	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.00036	0.00036	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000356	0.000356	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000356	0.000356	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000354	0.000354	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.00035	0.00035	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.00035	0.00035	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000349	0.000349	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000345	0.000345	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000343	0.000343	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000341	0.000341	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000339	0.000339	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000317	0.000317	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000315	0.000315	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000311	0.000311	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000305	0.000305	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000301	0.000301	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000292	0.000292	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000289	0.000289	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000282	0.000282	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.00028	0.00028	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000279	0.000279	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000276	0.000276	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000275	0.000275	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000257	0.000257	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000253	0.000253	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000241	0.000241	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	0.000237	0.000237	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	0.000232	0.000232	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000225	0.000225	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000218	0.000218	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000209	0.000209	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000204	0.000204	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	0.000203	0.000203	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	0.0002	0.0002	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	0.000183	0.000183	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000178	0.000178	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	0.000171	0.000171	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	0.000168	0.000168	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	0.000165	0.000165	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.000149	0.000149	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	0.000139	0.000139	CbGpPWpGaD
